Key Highlights

  • The fund holds 122 Israeli companies across pharmaceuticals, banking, defense and technology.
  • Teva Pharmaceutical, Bank Leumi and Bank Hapoalim are the largest positions.
  • Net asset value is $114.55, after a one-day gain of $3.08, or 2.77%.
  • The expense ratio is 0.59%, and distributions are paid semi-annually.

Israel's listed companies span pharmaceuticals, banking, defense and technology, and the iShares MSCI Israel ETF (NYSEARCA:EIS) offers a single-country route into that Equity market. Figures in this article are current to November 9, 2026. The fund seeks to track an index of Israeli equities, providing targeted exposure to companies listed in the country. Shares trade on NYSE Arca, and the fund has been listed since March 2008.

Fund Fact

Detail

Exchange and ticker

NYSE Arca: EIS

Fund inception

March 26, 2008

Net assets

$824.7 million

Net asset value

$114.55

Daily NAV change

+$3.08 (+2.77%)

Expense ratio

0.59%

30-day SEC yield

1.21%

Distribution frequency

Semi-annual

Number of holdings

122

Leading Sectors and Holdings

Teva Pharmaceutical Industries is the largest position, at about 13.0% of market value. Bank Leumi, Bank Hapoalim and Israel Discount Bank add banking exposure, which together accounts for roughly 20% of the portfolio.

Defense and technology names include Elbit Systems, Tower Semiconductor, Check Point Software and Nova. These holdings tie the fund to the country's defense and high-technology industries.

Trading and Price Movement

The net asset value rose $3.08 in the latest session, a gain of 2.77%. Shares outstanding total about 7.2 million, and the 30-day average Volume of roughly 82,000 shares suggests a smaller trading base. The 30-day median bid-ask spread of 0.28% is wider than many single-country funds.

The premium or discount to NAV was -0.23 in recent figures, indicating shares traded slightly below the value of holdings. Investors should expect spreads to matter more on smaller orders.

Costs, Income and Geopolitical Risk

The expense ratio is 0.59%, consisting of a management fee of the same amount. Semi-annual distributions are paid, and the 30-day SEC Yield of 1.21% describes a moderate income profile.

Israeli equities carry geopolitical and security risks, currency exposure, and sensitivity to domestic policy. The fund's concentration in a single country means these developments can have a larger effect than they would in a diversified global fund.

Final Word

The iShares MSCI Israel ETF offers a focused, single-country view of an equity market built around pharmaceuticals, banks, defense and technology companies. Its semi-annual income, mid-range fee and wider trading spread define its profile. Investors considering the fund will weigh single-market exposure against their broader regional allocation.